Polycythemia Vera Treatment Market - Top Companies and Manufacturers

Companies Dominating the Polycythemia Vera Treatment Landscape

Thermo Fisher Scientific Inc.

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Pfizer Inc.
Galena Biopharma
Bristol-Myers Squibb Company
Novartis AG
Eli Lilly and Company
PharmaEssentia Corporation
Bayer AG
Viatris Inc.
Teva Pharmaceuticals Industries Ltd

Browse Key Market Insights with Data Illustration:

Polycythemia Vera Treatment Market Size, Forecast Report 2036

In the News

PharmaEssentia Corporation, a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver novel hematology and oncology biologics, has announced reported that the first patients are now receiving treatment from ECLIPSE PV, a phase 3b clinical study evaluating an accelerated dosing regimen for cordeginterferon alfa. -2b-njft uses a prefilled syringe to treat polycythemia vera (PV) in adults.
In November 2021, the US Food and Drug Administration approved Besrem injection for adults with polycythemia vera, a blood disorder that causes overproduction of red blood cells. The extra cells thicken the blood, slowing blood flow and increasing the chance of blood clots.

Frequently Asked Questions (FAQ)

The growing prevalence of polycythemia vera and increasing awareness about polycythemia vera treatment are some of the major factors anticipated to drive

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2024 â€“ 2036.

The major players in the market are Pfizer Inc., Galena Biopharma, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, PharmaEssentia Corporation, Bayer AG, Viatris Inc. and others.

The oral segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Polycythemia Vera Treatment Market - Top Companies and Manufacturers

Companies Dominating the Polycythemia Vera Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the polycythemia vera treatment market?

What would be the CAGR of the polycythemia vera treatment market over the forecast period?

Who are the major players dominating the polycythemia vera treatment market?

Which segment captures the largest market size in the route of administration in the polycythemia vera treatment market?

Which region will provide more business opportunities for the growth of the polycythemia vera treatment market in the future?